Allspring Global Investments
BCAB icon

Allspring Global Investments’s BioAtla BCAB Stock Holding History

Allspring Global Investments’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-63
Closed -$5.39K – 2265
2023
Q3 		$5.39K Buy
+63
New +$8.03K ﹤0.01% 2669

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments's BCAB Position: Q4 2023 in Review

Allspring Global Investments sold out of BioAtla (BCAB) in Q4 2023, closing a stake of 63 shares — an estimated $5.39K sold.

Allspring Global Investments first reported a position in BCAB in Q3 2023 and held it in 1 quarter. The position peaked at $5.39K in Q3 2023. 79 funds tracked by Wall St. Rank hold BCAB as of Q4 2023.

  • Allspring Global Investments reported no remaining BioAtla position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 63 BioAtla shares in Q4 2023, an estimated $5.39K.
  • Allspring Global Investments first reported a position in BioAtla in Q3 2023 and held it in 1 quarter.
  • Allspring Global Investments's BioAtla position peaked at $5.39K in Q3 2023.
  • 79 funds tracked by Wall St. Rank held BioAtla as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.